Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/1999
05/20/1999WO1999024835A2 An immunoassay for procollagen-iii-c-terminal propeptide
05/20/1999WO1999024618A1 Methods for detection of mutations in myostatin variants
05/20/1999WO1999024607A2 DETECTION AND TYPING OF THE iceA GENE OF $i(HELICOBACTER PYLORI)
05/20/1999WO1999024601A1 Secreted protein nsl4
05/20/1999WO1999024583A1 Dna demethylase, therapeutic and diagnostic uses thereof
05/20/1999WO1999024582A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
05/20/1999WO1999024579A1 Novel era
05/20/1999WO1999024578A2 Neisserial antigens
05/20/1999WO1999024576A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999WO1999024572A1 Genes with restricted expression in mesencephalic dopaminergic neurons
05/20/1999WO1999024571A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999WO1999024570A1 Ciita-interacting proteins and methods of use therefor
05/20/1999WO1999024565A1 Methods and compositions for immunomodulation
05/20/1999WO1999024554A2 Isolation, characterization, and identification of dendritic like cells and methods of using same
05/20/1999WO1999024553A2 X-ray crystal comprising hiv-1 gp120
05/20/1999WO1999024473A1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
05/20/1999WO1999024472A2 Glycosylated antibodies and antibody fragments having reactive ketone groups
05/20/1999WO1999024078A1 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells
05/20/1999WO1999024077A2 Compositions and methods for targeted delivery of biologically-active factors
05/20/1999WO1999024069A1 Preventives and remedies for diffuse lung diseases
05/20/1999WO1999024066A2 Methods and compositions for enhancing immune response and for the production of in vitro mabs
05/20/1999WO1999024064A1 Antigen specific to meniere's disease and medical use thereof
05/20/1999WO1999024059A1 Pdgf-mediated microvascular communication and methods of use thereof
05/20/1999WO1999024056A1 Regulation of ocular angiogenesis
05/20/1999WO1999024045A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells
05/20/1999WO1999023867A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use
05/20/1999WO1999015653A3 Tie ligand homologues
05/20/1999WO1999015553A3 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
05/20/1999WO1999010505A3 Production of proteins in eggs
05/20/1999WO1999010494A3 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
05/20/1999WO1999009182A3 Rab proteins
05/20/1999WO1999007736A3 Lipoprotein-regulating medicaments
05/20/1999WO1999006557A3 Mammalian cell membrane proteins; related reagents
05/20/1999WO1998031796A8 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons
05/20/1999DE19750220A1 Producing polyoma virus-like particles in yeast for gene therapy, vaccine development and diagnosis
05/20/1999CA2671261A1 Neisserial antigens
05/20/1999CA2310213A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
05/20/1999CA2309598A1 Preventives and remedies for diffuse lung disease
05/20/1999CA2309559A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999CA2309383A1 Genes with restricted expression in mesencephalic dopaminergic neurons
05/20/1999CA2309360A1 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999CA2309320A1 Glycosylated antibodies and antibody fragments having reactive ketone groups
05/20/1999CA2309206A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells
05/20/1999CA2308768A1 125 human secreted proteins
05/20/1999CA2308606A1 Neisserial antigens
05/20/1999CA2308440A1 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use
05/20/1999CA2306254A1 Detection and typing of the icea gene of helicobacter pylori
05/20/1999CA2276250A1 Ciita-interacting proteins and methods of use therefor
05/20/1999CA2276080A1 Antigen specific to meniere's disease and medical use thereof
05/19/1999EP0916729A2 Novel reductase
05/19/1999EP0916727A2 Novel LysS
05/19/1999EP0916678A2 Method of clotting blood
05/19/1999EP0915980A2 Characterization of granulocytic ehrlichia and methods of use
05/19/1999EP0915977A1 B. burgdorferi polypeptides expressed in vivo
05/19/1999EP0915974A1 Modified tie-2-receptor ligands
05/19/1999EP0915973A1 Gene involved in cadasil, method of diagnosis and therapeutic application
05/19/1999EP0915970A1 Type c lectins
05/19/1999EP0915969A1 Method for preventing hiv-1 infection of cd4+ cells
05/19/1999EP0915904A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor
05/19/1999EP0915709A1 The use of proteinase inhibitors for prevention or reduction of bone resorption
05/19/1999EP0605627B1 Immunoassay for identifying alcoholics and monitoring alcohol consumption
05/19/1999EP0575410B1 Selection of specific proteins by a biological method
05/19/1999EP0500921B1 Na-k-atpase inhibiting natriuretic substances
05/19/1999CN1217024A Chemokine alpha 2
05/19/1999CN1217023A Canine OB protein compositions and method for recombinant prodn.
05/19/1999CN1216994A Apoptosis inducing molecule II
05/19/1999CN1216922A Porcine reproductive and respiratory syndrome vaccine
05/18/1999US5905027 Identifying neoplastic brain tissues based on binding affinty of antibodiesto antigens of chloride channels
05/18/1999US5905023 Maspin, a serpin with tumor suppressing activity
05/18/1999US5904922 Purified chicken antivenom in aqueous solution
05/18/1999CA1340544C Human tissue factor related dna segments, polypeptides and antibodies
05/14/1999WO1999023230A1 Reagents and methods useful for detecting diseases of the breast
05/14/1999WO1999023228A1 Svph1-26 dna and polypeptides
05/14/1999WO1999023222A1 Cysteine noose antibody libraries, means for their production and uses thereof
05/14/1999WO1999023221A2 Multivalent antigen-binding proteins
05/14/1999WO1999023220A1 Suppressor of cytokine signaling
05/14/1999WO1999023217A1 A novel gene and uses therefor
05/14/1999WO1999023212A1 Novel streptococcal ers
05/14/1999WO1999023207A1 Monoclonal antibodies to canine cd34
05/14/1999WO1999023108A1 Inducible phosphofructokinase and the warburg effect
05/14/1999WO1999022766A2 Use of anti-il-12 antibodies in transplantation rejection
05/14/1999WO1999022765A1 Control of lymphocyte localization by leep-cam activity
05/14/1999WO1999022764A1 Methods and compositions comprising glycoprotein glycoforms
05/14/1999WO1999014345A3 Medicament for treating a manifested lyme disease
05/14/1999WO1999009055A3 Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
05/14/1999WO1999008712A3 METHOD FOR INFLUENCING THE p53 LINKAGE IN TARGET GENES
05/14/1999WO1999008109A3 Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
05/14/1999WO1999006834A3 Methods for identifying ligand specific binding molecules
05/14/1999WO1999006068A3 Recombinant dimeric envelope vaccine against flaviviral infection
05/14/1999WO1999004265A8 Cancer associated nucleic acids and polypeptides
05/14/1999WO1999001764A3 METHOD FOR DETERMINING GnRH RECEPTORS
05/14/1999WO1999001475A3 Human antibody against a fusion (poly) peptide or protein presenting a part having at least six histidines
05/14/1999WO1998058965A3 B7-binding molecules for treating immune diseases
05/14/1999WO1998053838A3 A soluble laminin receptor precursor and methods to inhibit its interactions
05/14/1999WO1998047917A9 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2
05/14/1999WO1998047480A3 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium
05/14/1999WO1998014593A9 Human telomerase catalytic subunit
05/14/1999CA2308110A1 Svph1-26 dna and polypeptides
05/14/1999CA2308091A1 Inducible phosphofructokinase and the warburg effect
05/14/1999CA2308029A1 Reagents and methods useful for detecting diseases of the breast
1 ... 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 ... 1494